5th Global Genomic Medicine Collaborative Conference, Santiago, Chile

The 5th Global Genomic Medicine Collaborative Virtual Conference will be organized in Santiago, Chile, May 6-8, 2020.

The meeting will be organized by the Global Genomic Medicine Collaborative and the Universidad del Desarrollo as the local host and the Golden Helix Foundation, as G2MC partner. The 5th Global Genomic Medicine Collaborative Conference is the first to be organized in South America, following the successful events in the United States in 2014, in Singapore in 2015, in Athens in 2017 and in Cape Town in 2018 and will focus on the implementation of Genomic Medicine in low resource settings.

Leaders in Genomic Medicine across the globe will be attending this highly interactive meeting to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care. Representatives from the developed and the developing world will share challenges and strategies to overcome them. In addition we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to impact health care delivery.

In light of the coronavirus pandemic, G2MC has made the decision to hold the 5th Global Genomic Medicine Collaborative Conference, originally planned to take place in Santiago, Chile, as an abbreviated virtual meeting over the originally planned dates (May 6-8). We intend to reschedule the face-to-face meeting in Santiago for a later date.

Please regularly check this webpage as we will continue to post updates as they become available.

The 5th Global Genomic Medicine Collaborative Conference organizing Committee

 

Organized by:

Local organiser:

Organizing Partner:

Endorsed by:

The Global Genomic Medicine Collaborative

Overview

The Global Genomic Medicine Collaborative (G2MC) is an action collaborative among global leaders in the implementation of genomic medicine in clinical care. Arising from the 2014 Global Leaders in Genomic Medicine Summit, the purpose of G2MC is to identify opportunities and foster global collaborations for enabling the demonstration of value and the effective use of genomics in medicine. Engaging multiple stakeholders across the globe, the G2MC group, under the auspices of the Roundtable on Genomics and Precision Health, seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into health care delivery globally. To accomplish these goals, seven working groups were created, including communications, education, evidence, IT/bioinformatics, pharmacogenomics, policy, and a steering group to guide and support efforts among working groups.

Specifically, it is intended to:

• Serve as nexus, clearinghouse, and knowledge base for genomic medicine activities globally;
• Develop opportunities for global genomic medicine demonstration projects (implementation and outcomes research) and;
• Capture and disseminate best practices for genomic medicine (in bioinformatics, education, evidence, pharmacogenomics, policy) across the global genomic medicine community.

Current Activities

The purpose and goals of the Global Genomic Medicine Collaborative (G2MC):

• Develop projects with global participation
  • Opportunities to disseminate learnings for genomic medicine implementation
  • Educational platforms to support genomic medicine projects
  • Community engagement and access to global genomic medicine expertise
• Creation of a registry or catalog of genomic medicine projects and programs across the globe to stimulate collaboration and efficiency in translation
• Be a global policy forum for genomic medicine
  • Mapping the global genomic medicine landscape particularly as it relates to policy and implementation
• Global eradication of preventable Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Previous Conferences 

4th G2MC Conference; November 28-30, 2018, Cape Town, South Africa – Genomic Medicine implementation in low-resource settings

The meeting objectives were to:

• Highlight national efforts and organizations around the world that are implementing genomic medicine into practice
• Foster collaborations to enable the implementation of genomic medicine
• Identify and develop solutions for overcoming obstacles to genomic medicine implementation
• Sponsor the first Young Investigators Forum to foster the development of Young Investigators and provide networking and advancement opportunities

3rd G2MC Conference; April 27-29, 2017, Athens, Greece – Implementing Genomic Medicine into Practice

The meeting objectives were to:

• Highlight national efforts and organizations around the world that are implementing genomic medicine into practice
• Foster collaborations to enable the implementation of genomic medicine
• Discuss public health genomics approaches to catalyze implementation of genomic medicine
• Identify and develop solutions for overcoming obstacles to genomic medicine implementation
• Create a global tool box for implementation of genomic medicine into practice

2nd G2MC Conference; November 6-7, 2015, Singapore – Implementing Genomic Medicine into Practice

The meeting objectives were to:

• Highlight nations or organizations around the world that are implementing genomic medicine into practice
• Foster/facilitate collaborations to enable the implementation of genomic medicine
• Highlight best practices and lessons learned to enable others to effectively implement genomic medicine approaches
• Identify and develop solutions for overcoming obstacles to genomic medicine implementation
• Identify and discuss regulations and policies that impact the implementation of genomic medicine
• Create a global tool box for implementation of genomic medicine into practice

1st G2MC Conference; January 8-9, 2014, Washington DC, USA – Global Leaders in Genomic Medicine

The goals of the meeting were to:

• Identify areas of active translational and implementation research, potential common strategies, and opportunities for collaborative efforts.
• Identify common barriers to implementation of genomics in healthcare and a policy agenda relevant to advances in the field.
• Identify nations with unique capabilities (such as national healthcare systems) that may allow rapid implementation and measures of key outcomes.
• Discuss opportunities (such as national healthcare system) that may allow rapid implementation and measures of key outcomes.

Venue of the 5th Global Genomic Medicine Collaborative Conference

The 5th Global Genomic Medicine Collaborative Conference will be held in the SHERATON SANTIAGO HOTEL AND CONVENTION CENTER ***** (Ave, Sta María 1742, Santiago, Región Metropolitana, Chile).

Sheraton Santiago Hotel & Convention Center is one of the best Santiago lodging choices with numerous amenities for guests. The hotel is situated minutes away from Uruguay Park, close to the San Cristobal Hill and also in close proximity of Municipal Market of Providencia and Sculpture Park.

The hotel has 379 air-conditioned rooms with several amenities, such as outdoor tennis courts and a 24-hour health club and also includes 4 restaurants and a coffee shop/café. Guests can get around on the shuttle (surcharge), which operates within 50 km. A roundtrip airport shuttle is provided for a surcharge (available 24 hours), and self parking (subject to charges) is available onsite.

Sheraton Santiago Hotel & Convention Center has a 7575 square feet (704 square meters) of space consisting of conference space and a meeting room.

To reserve your room at the Sheraton Santiago Hotel and Conference Center, please follow the next link:

Conference Organizing Committee

G2MC Co-Chairs 

Geoff Ginsburg; Director, Duke Center for Applied Genomics and Precision Medicine; Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

Catalina Correa-Lopez; Chief Scientific Officer, Genome British Columbia, Vancouver, Canada

George P. Patrinos; Professor of Pharmacogenomics and Pharmaceutical Biotechnology and Head, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Department of Pharmacy, Patras Greece

Organizing Committee 

Co-Chairs

Gabriella Repetto, Santiago, Chile (Co-Chair)

Bruce Korf, Tuscallosa, AL, USA (Co-Chair)

Members

Ricardo Armisen, Macul, Chile

Pilar Carvallo, Santiago, Chile

Geoff Ginsburg, Durham, NC, USA

Lovemore Gwanzura, Harare, Zimbabwe

Stefania Koutsilieri, Patras, Greece

Rongling Li, Wahington, DC, USA

Catalina Lopez-Correa, Vancouver, Canada

Ursula Matte, Porto Alegre, Brazil

Gert Matthijs, Leuven, Belgium

George P. Patrinos, Patras, Greece

Teji Rakhra-Burris, Durham, NC, USA

Boris Rebolledo, Santiago, Chile

Gad Rennert, Tel-Aviv, Israel

Alan Shuldiner, Baltimore, MD, USA

Ambroise Wonkam, Cape Town, South Africa

Grant Wood,  Salt Lake City, UT, USA

Young Investigators Forum Planning Committee

George P. Patrinos, – Patras, Greece (Co-Chair)

Catalina Lopez-Correa, Vancouver, Canada (Co-Chair)

Stefania Koutsilieri, Patras, Greece

Ursula Matte, Porto Alegre, Brazil

Boris Rebolledo , Santiago, Chile

Draft scientific program

DAY 1: MAY 6, 2020

08:00-13:00 Registration [location]

08:00-12:00 Young Investigators’ Forum [location]

08:00-08:05 Welcoming Remarks – Chairs, YIF Planning Committee

                  George P. Patrinos; University of Patras, Department of Pharmacy, Patras, Greece

                  Catalina Lopez-Correa; Ruta N Medellin, Colombia

08:05-10:55 Young Investigator Presentations

10:55-11:10  COFFEE BREAK [location]

11:10-11:40 Career Development Panel

                  Moderators: Stefania Koutsilieri and Boris Rebolledo

                  Panel Members: Alan Shuldiner (USA), Ricardo Armisen (Chile), Guilherme Suarez-Kurtz (Brazil),

                                         Juergen Reichardt (Australia), Catalina Lopez-Correa (Colombia)

11:40-12:00 Young Investigator Flash Talks

12:00-13:30 Lunch and Poster Session[location]

13:30-13:45 G2MC 5th International G2MC Conference[location]

                  Welcoming Remarks and opening statements

                  Gabriela Repetto; Universidad del Desarrollo, Santiago, Chile

                  Bruce Korf; University of Alabama, USA

13:45-13:50  Keynote Introduction:  Gabriela Repetto

13:50-14:20 Keynote lecture: TBD 

                   Andres Couve

                   Minister of Science and Innovation, Chile

Session I: Genomic Landscape in Latin America                                         

Moderators: Gabriela Repetto (Universidad del Desarrollo, Chile) and Ricardo Armisen (Universidad del Desarrollo, Chile)

14:20-14:25 Moderator introductions 

14:25-16:25 Existing National Initiatives in Latin America

Population Genomics Initiative, Brazil

Lygia da Veiga Pereira

Brazil

Patient Participation and Advocacy

Cecilia Rodriguez

Patients Alliance, Chile 

Development of an actionable NGS cancer panel in the Chilean Health Care system

Katherine Marcelain, PhD; Universidad de Chile

Latin American Hereditary Cancer Network

Mev Dominguez-Valentin, PhD; Peru and Oslo Cancer Institute

Latin American PGx Network

Bernard Esquivel, MD, PhD; Latin American Association of Precision Medicine (ALAMP); OneOme

Data sharing is necessary for implementation of Genomic Medicine

Iscia Lopes-Cendes

Brazil

Education and workforce

Silvia Castillo

Universidad de Chile

16:35-17:15 Panel Discussion

Moderator: Ricardo Armisen

Panel members: Lygia de Veiga Pereira, Cecilia Rodriguez, Katherine Marcelain, May Dominguez-Valentin, Bernard Esquivel, Iscia Lopes-Cendes, Silia Castillo

18:00 WELCOME COCKTAIL RECEPTION 

DAY 2: MAY 7, 2020

08:00-08:05 Keynote Introduction

08:05-08:35 Keynote: TBD  

Dame Sue Hill 

National Health Service, England

Session II: Genomics of Common Disorders

Moderators: George Patrinos and Alan Shuldiner

08:35-10:05 Large-scale National Initiatives outside of Latin America                                            

International Hundred K+ Cohorts Consortium 

Teri Manolio, National Human Genome Research Institute,  USA

100K RCT in Israel, Clalit

Gad Rennert 

Israel

Genomic Medicine and Pharmacogenomics Implementation; The Genome of Greeece (GoGreece) Initiative 

George P. Patrinos

University of Patras Department of Pharmacy, Patras, Greece

Korean and Asian Genome Projects

TBD

Macrogen

Polygenic Risk Scores and Common Disease

Emear Kenney 

Mount Sinai School of Medicine, USA

Addressing antimicrobial resistance and the One Health Paradigm

Rafael Araos

Clinica Alemana, Universidad del Desarrollo, Chile

Maule/MAUCO cohort 

Catterina Ferreccio

Chile 

10:05-10:35 Panel Discussion                    

10:35-11:00 COFFEE BREAK

Session III: Genomics of Rare Disorders

Moderators: Bruce Korf and Gert Mattijs

11:00-12:30 Undiagnosed Diseases Network International

IRDIRC DSC presentation on rare diseases

Juergen Reichardt

Australian Institute of Tropical Health and Medicine, Australia

Medical Genetics Leader in Colombia

Fernando Suarez (to be invited)

Javeriana University, Colombia

Regional rare disease diagnostic programs

Cecilia Poli 

Clínica Alemana Universidad del Desarrollo, Chile

Return of Results and Scaling their Model

Kelly East, Hudson Alpha

12:30-13:00 Panel Discussion

                  Moderators: Bruce Korf, Gert Matthijs

                  Members: Juergen Reichardt, Cecilia Poli, Kelly East

13:00-13:15 Instructions to Breakout Groups – Alan Shuldiner

13:15-15:15 LUNCH BREAK 

13:30-15:15 G2MC Steering Committee Meeting (closed session)

15:30-17:00 Breakout Groups

i) Education Working Group,

   Vajira Dissanayake (University of Colombo, Sri Lanka),

   Bruce Korf (University of Alabama, USA)

ii) Policy Working Group

    Dame Sue Hill, National Health Service, UK

    Catalina Lopez-Correa, Ruta N Medellin, Colombia      

iii) Genomic Medicine Flagship Projects Working Group

    Pharmacogenomics – George P. Patrinos, University of Patras, Greece

    Rare Diseases – Vajira Dissanayake (University of Colombo, Sri Lanka), Alan Shuldiner (Regeneron Pharmaceuticals,

                           USA)

    Cancer – Federico Innocenti (University of North Carolina at Chapel Hill, USA)

    Family History – Grant Wood

iv) Advocacy Working Group

    Vajira Dissayanake, University of Colombo, Sri Lanka

    Catalina Lopez-Correa, Ruta N Medellin, Colombia

v) Evidence Working Group

    Marc Abramowitz, Geneva University Hospitals (HUG)< Geneva Switzerland

   Fahd Al-Mulla, Kuwait University, Kuwait 

18:30 Depart for Dinner

19:00 DINNER

DAY 3: May 8th, 2020

08:00-08:05 Keynote Introduction: Speaker TBD

08:05-08:35 Keynote: TBD

Andrew Sinclair, 

Murdoch Children’s Research Institute, Australia

Session IV: Solutions to Roadblocks

Moderators: Geoff Ginsburg (Duke University, USA) and Catalina Lopez-Correa (Ruta N Medellin, Colombia)

08:35-10:35 Challenges in implementing genomic medicine in Latin America

Gabriela Repetto, 

Universidad del Desarrollo, Chile

Implementing Genomic Medicine in Diverse Care Settings: The IGNITE Network

Geoff Ginsburg, 

Duke University, USA

Implementing genetic risk testing in Africa

Elissa Prichep or Genya Dana 

World Economic Forum

Evaluating technologies for genomic medicine in LMICs

Manuel Espinoza 

Universidad Catolica, Chile

Education: Lessons from genomic medicine in first nations

Catalina Lopez-Correa 

Ruta N Medellin, Colombia

Genomic competence,workforce development,engagement and education in New Zealand

Michelle Thunders

New Zealand

ISCC Update

Rih Haspel

USA

10:35-11:05 COFFEE BREAK

11:05-11:45 Panel discussion

                  Moderators: Geoff Ginsburg and Catalina Lopez-Correa

                  Members: Gabriela Repetto, Elisa Prichep or Genya Dana, Michelle Thunders, Rich Haspel

11:45-13:00 LUNCH

Session V: Breakout Sessions

13:00-15:00 Report Back from Breakout Groups – Alan Shuldiner (Regeneron Pharmaceuticals, USA), Moderator

i) Education Working Group, 

   Vajira Dissanayake (University of Colombo, Sri Lanka), 

   Bruce Korf (University of Alabama, USA)

ii) Policy Working Group

    Dame Sue Hill, National Health Service, UK

    Catalina Lopez-Correa, Ruta N Medellin, Colombia      

iii) Genomic Medicine Flagship Projects Working Group

    Pharmacogenomics – George P. Patrinos, University of Patras, Greece

    Rare Diseases – Vajira Dissanayake (University of Colombo, Sri Lanka), Alan Shuldiner (Regeneron Pharmaceuticals,

                           USA)

    Cancer – Federico Innocenti (University of North Carolina at Chapel Hill, USA)

    Family History – Grant Wood

iv) Advocacy Working Group

    Vajira Dissayanake, University of Colombo, Sri Lanka

    Catalina Lopez-Correa, Ruta N Medellin, Colombia

v) Evidence Working Group

    Marc Abramowitz, Geneva University Hospitals (HUG)< Geneva Switzerland

   Fahd Al-Mulla, Kuwait University, Kuwait

15:00-15:30 Young Investigator Poster Awards Announcement

15:30-15:45 Closing remarks and next steps

 Gabriela Repetto and Bruce Korf; 5th G2MC International Conference Co-Chairs

15:45-16:00 Announcement of 6th G2MC Conference location and adjournment

                   Catalina Lopez-Correa, Geoff Ginsburg, George P. Patrinos; G2MC Co-Chairs 

17:00-18:30 G2MC Executive Committee Meeting (closed session)

Sponsors

We are grateful to the following academic and corporate entities who have generously supported the 5th Global Genomic Medicine Collaborative Conference

Registration

General registration for the 5th Global Genomic Medicine Collaborative virtual conference is now open and can be accessed through the next link

To reserve your room at the Sheraton Santiago Hotel and Conference Center, please follow the next link

We are pleased to be able to offer this global conference at no fee to you through the generosity of sponsors. However, as space is limited, we as that you register so we may manage space, food, and other conference amenities. 

Should you register and then discover you will not be able to attend, please let us know so we may open the space for other attendees.

Young Investigators who plan to submit an abstract should do so through the ‘Abstract Submission’ tab, BUT should also register to attend the meeting by following the instructions in this section. 

Abstract submission

G2MC is excited to showcase Young Investigators work at the 5th G2MC Conference in May 2020 and look forward to receiving abstracts from Young Investigators who meet the following criteria in Genomic Medicine Implementation:

– Graduate student,

– Post-doctoral researchers,

– Junior faculty within 2 years of postdoc, residency, or fellowship, and

– Investigators new to genomic medicine within the past two years.

Submitted abstracts should contain recent scientific and technological developments pertaining to genomic medicine implementation in limited-resource settings and we strongly encouraged presentation of original work and results. Abstracts are accepted in the English language only. All abstracts should be prepared according to the Abstract template. Abstracts can only be submitted through Online Submission (link below), and submitters should also register to attend the meeting through the Conference Registration website tab. 

Limited support is available for Young Investigators to travel to attend the conference. At this time, we are pleased to announce that the Universidad del Desarrollo has pledged limited travel grants for Latin American Young Investigators. Allocation of the grants will be made during the abstract judging process and you will be notified of this support along with the judging results. G2MC hopes to raise more support to enable Young Investigators from across the globe to attend and will announce those opportunities when they arise.

Hotel accommodations for three nights will be provided by the Conference for Young Investigators chosen to provide a platform presentation during the meeting.

G2MC acknowledges that many investigators are now moving to the field of genomic implementation as this field grows. To recognize and encourage their grown, we are now including these ‘New to the field’ investigators in our selection criteria.

Ten abstracts will be selected by our YIF planning committee for the platform presentations and up to 20 chosen to participate in the Flash Talk session. All qualified abstracts will be chosen for poster presentations. 

Limited support may be available for Young Investigators to travel to attend the conference. The YIF Planning committee will contact you when support becomes available. Hotel accommodations for three nights will be provided by the Conference for Young Investigators chosen to provide a platform presentation during the meeting.

The abstract submission deadline is 15 February 2020. Young Investigators should plan on submitting the abstract, a brief biography, and a Curriculum Vitae. Please click on the link below for guidelines and to access /download the Abstract template.